Vernal Biosciences Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 63

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $41M

  • Investors
  • 5

Vernal Biosciences General Information

Description

Operator of an mRNA manufacturing company intended to provide high purity from concept to clinical trials, on a transactional basis. The company focuses on mRNA and LNP-mRNA manufacturing for use in cells, animals, and humans to address all mRNA-based life science needs, enabling research professionals with on-demand, high-purity mRNA for all of their R&D needs.

Contact Information

Website
www.vernal.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 261 Mountain View Drive
  • Colchester, VT 05446
  • United States
+1 (802) 000-0000

Vernal Biosciences Timeline

202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vernal Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 14-Jun-2023 $41M 000.00 0000 Completed Generating Revenue
1. Seed Round 24-May-2021 00.00 00.00 00.00 Completed Generating Revenue
To view Vernal Biosciences’s complete valuation and funding history, request access »

Vernal Biosciences Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Seed 000,000 00.000000 00.00 00.00 00 00.00 00
To view Vernal Biosciences’s complete cap table history, request access »

Vernal Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of an mRNA manufacturing company intended to provide high purity from concept to clinical trials, on a transact
Drug Discovery
Colchester, VT
63 As of 2023
000.00
000 0000-00-00
00000000000 000.00

00000

ure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla
0000 000000000
South San Francisco, CA
00 As of 0000
00000
0000 0000-00-00
00000000000 00000

000000

quat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolo
0000 000000000
San Diego, CA
000 As of 0000
00000
00000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Vernal Biosciences Competitors (51)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Verge Genomics Venture Capital-Backed South San Francisco, CA 00 00000 00000000000 00000
00000000 000000000 Formerly VC-backed San Diego, CA 000 00000 00000000
00000000 000000000 Formerly VC-backed Solana Beach, CA 00 00000 000000000 00000
0000000 Venture Capital-Backed Niel, Belgium 00 00000 00000000000 00000
0000000 Venture Capital-Backed Framingham, MA 00 000.00 00000000000 000.00
You’re viewing 5 of 51 competitors. Get the full list »

Vernal Biosciences Executive Team (1)

Name Title Board Seat Contact Info
Christian Cobaugh Ph.D Founder, Chief Executive Officer, President & Board Member
To view Vernal Biosciences’s complete executive team members history, request access »

Vernal Biosciences Board Members (6)

Name Representing Role Since
Christian Cobaugh Ph.D Vernal Biosciences Founder, Chief Executive Officer, President & Board Member 000 0000
Daniella Kranjac Dynamk Capital Board Member 000 0000
David Anderson Ph.D Ampersand Capital Partners Board Member 000 0000
Errik Anderson Alloy Therapeutics Board Member 000 0000
Gustavo Mahler Ph.D Dynamk Capital Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Vernal Biosciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vernal Biosciences Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Ampersand Capital Partners Growth/Expansion Minority 000 0000 000000 0
Charles River Laboratories International Corporation Minority 000 0000 000000 0
Dynamk Capital Venture Capital Minority 000 0000 000000 0
Alloy Therapeutics VC-Backed Company Minority 000 0000 000000 0
VCET Capital Accelerator/Incubator Minority 000 0000 000000 0
To view Vernal Biosciences’s complete investors history, request access »

Ready to get started?

Request a free trial